The immunofluorescence staining results (Fig. 6b) revealed increased CD44, CD10, vimentin, and carbonic anhydrase IX (a ccRCC biomarker) expression and decreased E-cadherin levels in the kidneys of 3MC-treated mice. This evidence concerns the gene CDH1 and nonpapillary renal cell carcinoma.